137 related articles for article (PubMed ID: 9328046)
1. Effects of glial cell line-derived neurotrophic factor on the nigrostriatal dopamine system in rodents and nonhuman primates.
Gash DM; Gerhardt GA; Hoffer BJ
Adv Pharmacol; 1998; 42():911-5. PubMed ID: 9328046
[No Abstract] [Full Text] [Related]
2. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
[TBL] [Abstract][Full Text] [Related]
3. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model.
Björklund A; Kirik D; Rosenblad C; Georgievska B; Lundberg C; Mandel RJ
Brain Res; 2000 Dec; 886(1-2):82-98. PubMed ID: 11119690
[TBL] [Abstract][Full Text] [Related]
4. Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Eberhardt O; Coelln RV; Kugler S; Lindenau J; Rathke-Hartlieb S; Gerhardt E; Haid S; Isenmann S; Gravel C; Srinivasan A; Bahr M; Weller M; Dichgans J; Schulz JB
J Neurosci; 2000 Dec; 20(24):9126-34. PubMed ID: 11124990
[TBL] [Abstract][Full Text] [Related]
5. Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease.
Rosenblad C; Martinez-Serrano A; Björklund A
Neuroscience; 1998 Jan; 82(1):129-37. PubMed ID: 9483509
[TBL] [Abstract][Full Text] [Related]
6. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery.
Lapchak PA; Miller PJ; Collins F; Jiao S
Neuroscience; 1997 May; 78(1):61-72. PubMed ID: 9135089
[TBL] [Abstract][Full Text] [Related]
7. GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice.
Date I; Aoi M; Tomita S; Collins F; Ohmoto T
Neuroreport; 1998 Jul; 9(10):2365-9. PubMed ID: 9694229
[TBL] [Abstract][Full Text] [Related]
8. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo.
Tomac A; Lindqvist E; Lin LF; Ogren SO; Young D; Hoffer BJ; Olson L
Nature; 1995 Jan; 373(6512):335-9. PubMed ID: 7830766
[TBL] [Abstract][Full Text] [Related]
9. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor.
Kirik D; Rosenblad C; Björklund A
Eur J Neurosci; 2000 Nov; 12(11):3871-82. PubMed ID: 11069582
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective and neurorestorative properties of GDNF.
Gash DM; Zhang Z; Gerhardt G
Ann Neurol; 1998 Sep; 44(3 Suppl 1):S121-5. PubMed ID: 9749583
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons.
Akerud P; Alberch J; Eketjäll S; Wagner J; Arenas E
J Neurochem; 1999 Jul; 73(1):70-8. PubMed ID: 10386956
[TBL] [Abstract][Full Text] [Related]
12. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
Rosenblad C; Kirik D; Devaux B; Moffat B; Phillips HS; Björklund A
Eur J Neurosci; 1999 May; 11(5):1554-66. PubMed ID: 10215908
[TBL] [Abstract][Full Text] [Related]
13. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
[TBL] [Abstract][Full Text] [Related]
14. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
Rosenblad C; Kirik D; Björklund A
Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
[TBL] [Abstract][Full Text] [Related]
15. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats.
Lu X; Hagg T
J Comp Neurol; 1997 Nov; 388(3):484-94. PubMed ID: 9368855
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of GDNF against 6-OHDA in young and aged rats.
Fox CM; Gash DM; Smoot MK; Cass WA
Brain Res; 2001 Mar; 896(1-2):56-63. PubMed ID: 11277973
[TBL] [Abstract][Full Text] [Related]
17. Glial cell line-derived neurotrophic factor: the lateral cerebral ventricle as a site of administration for stimulation of the substantia nigra dopamine system in rats.
Martin D; Miller G; Fischer N; Diz D; Cullen T; Russell D
Eur J Neurosci; 1996 Jun; 8(6):1249-55. PubMed ID: 8752595
[TBL] [Abstract][Full Text] [Related]
18. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats.
Wang Y; Tien LT; Lapchak PA; Hoffer BJ
Cell Tissue Res; 1996 Nov; 286(2):225-33. PubMed ID: 8854891
[TBL] [Abstract][Full Text] [Related]
19. Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned rats.
Bowenkamp KE; Lapchak PA; Hoffer BJ; Miller PJ; Bickford PC
Exp Neurol; 1997 May; 145(1):104-17. PubMed ID: 9184114
[TBL] [Abstract][Full Text] [Related]
20. Histological effects of intraputaminal infusion of glial cell line-derived neurotrophic factor in Parkinson disease model macaque monkeys.
Oiwa Y; Nakai K; Itakura T
Neurol Med Chir (Tokyo); 2006 Jun; 46(6):267-75; discussion 275-6. PubMed ID: 16794346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
